These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 24175062)

  • 1. Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues.
    Ross S; Anand SS; Joseph P; Paré G
    JRSM Cardiovasc Dis; 2012 Apr; 1(1):. PubMed ID: 24175062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological quality of pharmacogenetic studies: issues of concern.
    Jorgensen AL; Williamson PR
    Stat Med; 2008 Dec; 27(30):6547-69. PubMed ID: 18837075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics in Stroke and Cardiovascular Disease: State of the Art.
    Ross S; Krebs K; Paré G; Milani L
    Stroke; 2023 Jan; 54(1):270-278. PubMed ID: 36325912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of osteoporosis: what is the evidence?
    Marini F; Brandi ML
    Curr Osteoporos Rep; 2012 Sep; 10(3):221-7. PubMed ID: 22760517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics of antipsychotics: recent progress and methodological issues.
    Zhang JP; Malhotra AK
    Expert Opin Drug Metab Toxicol; 2013 Feb; 9(2):183-91. PubMed ID: 23199282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
    Tavakolpour S; Darvishi M; Ghasemiadl M
    Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics and personalized medicine: the future for drug prescribing.
    Mitri Z; Esmerian MO; Simaan JA; Sabra R; Zgheib NK
    J Med Liban; 2010; 58(2):101-4. PubMed ID: 20549897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Companion diagnostics: significances and issues in its clinical application].
    Miyachi H
    Rinsho Byori; 2011 Jun; 59(6):602-9. PubMed ID: 21815484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].
    Hafner S; Haubensak S; Paul T; Zolk O
    Dtsch Med Wochenschr; 2016 Oct; 141(21):e183-e202. PubMed ID: 27750332
    [No Abstract]   [Full Text] [Related]  

  • 13. Methodological and statistical issues in pharmacogenomics.
    Peters BJ; Rodin AS; de Boer A; Maitland-van der Zee AH
    J Pharm Pharmacol; 2010 Feb; 62(2):161-6. PubMed ID: 20487194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical design of personalized medicine interventions: the Clarification of Optimal Anticoagulation through Genetics (COAG) trial.
    French B; Joo J; Geller NL; Kimmel SE; Rosenberg Y; Anderson JL; Gage BF; Johnson JA; Ellenberg JH;
    Trials; 2010 Nov; 11():108. PubMed ID: 21083927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics of treatments for pancreatic cancer.
    El Hassouni B; Li Petri G; Liu DSK; Cascioferro S; Parrino B; Hassan W; Diana P; Ali A; Frampton AE; Giovannetti E
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):437-447. PubMed ID: 31100206
    [No Abstract]   [Full Text] [Related]  

  • 16. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine: is it a pharmacogenetic mirage?
    Shah RR; Shah DR
    Br J Clin Pharmacol; 2012 Oct; 74(4):698-721. PubMed ID: 22591598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacogenetics of anticancer drugs].
    de Chaisemartin L; Loriot MA
    Pathol Biol (Paris); 2005 Mar; 53(2):116-24. PubMed ID: 15708657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence and resources to implement pharmacogenetic knowledge for precision medicine.
    Caudle KE; Gammal RS; Whirl-Carrillo M; Hoffman JM; Relling MV; Klein TE
    Am J Health Syst Pharm; 2016 Dec; 73(23):1977-1985. PubMed ID: 27864205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.